The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
Vicky Chuong(National Institutes of Health), Lorenzo Leggio(National Institute on Drug Abuse), Renata C.N. Marchette(National Institutes of Health), Marisa Roberto(Scripps Research Institute), Sophie K. Elvig(National Institutes of Health), George F. Koob(American Society of Addiction Medicine), Leandro F. Vendruscolo(National Institute on Drug Abuse), Mehdi Farokhnia(National Institute on Drug Abuse), Sophia Khom(Scripps Research Institute), Claire Pince(National Institutes of Health), Roman Vlkolinský(Scripps Research Institute)
Cited by 200
Related Papers
Neurocircuitry of Addiction
|Neuropsychopharmacology|2009|5.2k
The Development and Maintenance of Drug Addiction
|Neuropsychopharmacology|2013|557
Corticotropin-Releasing Factor within the Central Nucleus of the Amygdala Mediates Enhanced Ethanol Self-Administration in Withdrawn, Ethanol-Dependent Rats
|Journal of Neuroscience|2006|392
What Keeps Us Awake: the Neuropharmacology of Stimulants and Wakefulness Promoting Medications
|SLEEP|2004|310
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework
|Neuropsychopharmacology|2019|272